These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 28601428)

  • 41. The VEGF paradox: Does diabetic retinopathy protect from age related macular degeneration?
    Saravia M; Zeman L; Ingolotti M; Schlaen A
    Med Hypotheses; 2017 Nov; 109():156-161. PubMed ID: 29150277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B; Sun JH; Xiang FF; Liu L; Li WJ
    Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far.
    Whitmire W; Al-Gayyar MM; Abdelsaid M; Yousufzai BK; El-Remessy AB
    Mol Vis; 2011 Jan; 17():300-8. PubMed ID: 21293735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
    J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetic retinopathy and angiogenesis.
    Crawford TN; Alfaro DV; Kerrison JB; Jablon EP
    Curr Diabetes Rev; 2009 Feb; 5(1):8-13. PubMed ID: 19199892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy.
    Amato R; Biagioni M; Cammalleri M; Dal Monte M; Casini G
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3066-76. PubMed ID: 27286364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders.
    Cehofski LJ; Honoré B; Vorum H
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression.
    D'Amico AG; Maugeri G; Rasà DM; La Cognata V; Saccone S; Federico C; Cavallaro S; D'Agata V
    J Cell Physiol; 2018 Feb; 233(2):1120-1128. PubMed ID: 28436035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reprogramming Müller Glia to Regenerate Retinal Neurons.
    Lahne M; Nagashima M; Hyde DR; Hitchcock PF
    Annu Rev Vis Sci; 2020 Sep; 6():171-193. PubMed ID: 32343929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypoxia-inducible factor (HIF)/vascular endothelial growth factor (VEGF) signaling in the retina.
    Kurihara T; Westenskow PD; Friedlander M
    Adv Exp Med Biol; 2014; 801():275-81. PubMed ID: 24664708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vascular endothelial growth factor in eye disease.
    Penn JS; Madan A; Caldwell RB; Bartoli M; Caldwell RW; Hartnett ME
    Prog Retin Eye Res; 2008 Jul; 27(4):331-71. PubMed ID: 18653375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy.
    Deliyanti D; Alrashdi SF; Tan SM; Meyer C; Ward KW; de Haan JB; Wilkinson-Berka JL
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):815-825. PubMed ID: 29411009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular pathogenesis of retinal and choroidal vascular diseases.
    Campochiaro PA
    Prog Retin Eye Res; 2015 Nov; 49():67-81. PubMed ID: 26113211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implication of VEGF and aquaporin 4 mediating Müller cell swelling to diabetic retinal edema.
    Kida T; Oku H; Horie T; Fukumoto M; Okuda Y; Morishita S; Ikeda T
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1149-1157. PubMed ID: 28303331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF-1α-VEGF pathway in oxygen-induced retinopathy mice.
    Xu Y; Lu X; Hu Y; Yang B; Tsui CK; Yu S; Lu L; Liang X
    J Pineal Res; 2018 May; 64(4):e12473. PubMed ID: 29411894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific involvement of SRC family kinase activation in the pathogenesis of retinal neovascularization.
    Werdich XQ; Penn JS
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5047-56. PubMed ID: 17065526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autocrine and Paracrine Secretion of Vascular Endothelial Growth Factor in the Pre-Hypoxic Diabetic Retina.
    Grigsby JG; Allen DM; Ferrigno AS; Vellanki S; Pouw CE; Hejny WA; Tsin ATC
    Curr Diabetes Rev; 2017; 13(2):161-174. PubMed ID: 27748176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy.
    Babapoor-Farrokhran S; Jee K; Puchner B; Hassan SJ; Xin X; Rodrigues M; Kashiwabuchi F; Ma T; Hu K; Deshpande M; Daoud Y; Solomon S; Wenick A; Lutty GA; Semenza GL; Montaner S; Sodhi A
    Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3030-9. PubMed ID: 26039997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glial cell regulation of neuronal activity and blood flow in the retina by release of gliotransmitters.
    Newman EA
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1672):. PubMed ID: 26009774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.